Anticorps Recombinant de lapin anti-spike protein
spike protein Recombinant Antibody for WB
Hôte / Isotype
Lapin / IgG
Réactivité testée
Virus
Applications
WB
Conjugaison
CoraLite® Plus 750 Fluorescent Dye
CloneNo.
4I18
N° de cat : CL750-82734-4
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | Protéine recombinante, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL750-82734-4 cible spike protein dans les applications de WB et montre une réactivité avec des échantillons Virus
Réactivité | Virus |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | spike protein Protéine recombinante Ag30684 |
Nom complet | SARS-CoV-2 Spike Protein |
Masse moléculaire calculée | 141 kDa |
Numéro d’acquisition GenBank | NC_045512 |
Symbole du gène | SARS-COV-2 |
Identification du gène (NCBI) | 43740568 |
Conjugaison | CoraLite® Plus 750 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 755 nm / 780 nm |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA |
Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Coronaviruses (CoVs) infect human and animals and cause varieties of diseases, including respiratory, enteric, renal, and neurological diseases. CoV uses its spike protein to recognize ACE2 as its receptors and mediate membrane fusion and virus entry into host cells(PMID: 32221306). Each monomer of trimeric S protein is about 180 kDa, and contains two subunits, S1 and S2,S1 recognizes and binds to host receptors, and subsequent conformational changes in S2 facilitate fusion between the viral envelope and the host cell membrane(PMID: 19198616). Although the amino acid sequences of the S-glycoprotein were found to be different between the various HCoV, the structures showed high similarity, but the best 3D structural overlap shared by SARS-CoV and SARS-CoV-2, consistent with the shared ACE2 predicted receptor (PMID: 32522207). The spike protein of CoVs can be a target for vaccine and therapeutic development (PMID: 19198616). 28901-1-AP is specific for spike protein of SARS-COV-2, that antigen region is 428-506aa.